Pregnancy Trials in New York, United States
Conditions / Pregnancy / New York, United States
Pregnancy is a medical condition with active clinical research programs worldwide.
54 total trials for this combination
Showing top 10 of 54 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00000751 | A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) | COMPLETED | PHASE3 |
| NCT00000828 | Study of Perinatal Transmission of Zidovudine-Resistant HIV Among Pregnant Women Treated With Zidovudine | COMPLETED | — |
| NCT00000869 | A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies | COMPLETED | PHASE3 |
| NCT00000920 | Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns | COMPLETED | PHASE1 |
| NCT00041964 | A Study of HIV Levels During Pregnancy and After Childbirth | COMPLETED | — |
| NCT00017719 | Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy | COMPLETED | PHASE3 |
| NCT00000839 | A Phase I Trial to Evaluate Didanosine (ddI) in HIV-Infected Pregnant Women | COMPLETED | PHASE1 |
| NCT00001135 | A Study of Nevirapine to Prevent HIV Transmission From Mothers to Their Infants | COMPLETED | PHASE3 |
| NCT00017797 | Problems Associated With the Use of Anti-HIV Drugs in HIV-Infected Pregnant Women | COMPLETED | — |
| NCT00000960 | The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants | COMPLETED | PHASE3 |